Abstract: Background: The rate of severe cutaneous adverse drug reactions is low, and these reactions can result in death or disability. An evidence-based epidemiological study of severe cutaneous adverse drug reactions in China has not been reported. oBjective: The aim of this study was to analyze epidemiology and characteristics of severe cutaneous adverse drug reactions of Chinese inpatients during the recent 15 years with meta-analysis. Methods: We retrospectively reviewed Chinese literature reporting severe cutaneous adverse drug reactions and collecting data from 2000 to 2015, which were in accordance with our inclusion criteria. All included data were analyzed with the Launch Open Meta-Analyst software. results: Twenty-five articles involving 928 cases with severe cutaneous adverse drug reactions were included. Men to women ratio was 1.14:1. Twenty-one per cent of the patients had drug allergy history. Antibiotics (26.0%), sedative hypnotics and anticonvulsants (21.6%), and antipyretic analgesics (17.1%) were the most common causative drugs. The most frequent clinical subtype was Stevens-Johnson syndrome (50.1%), followed by toxic epidermal necrolysis (25.4%), exfoliative dermatitis (21.0%) and drug-induced hypersensitivity syndrome (1.6%). In addition to skin rashes, patients with severe cutaneous adverse drug reactions suffered mostly from fever (73%), and blood routine abnormality (66.7%). study liMitations: This meta-analysis is limited by its retrospective design and by its methodological variation. conclusion: The most common causative drugs were antibiotics and sedative hypnotics and anticonvulsants. Stevens-Johnson syndrome was the most frequent clinical subtype of severe cutaneous adverse drug reactions. In addition to skin rashes, patients with severe cutaneous adverse drug reactions suffered mostly from fever, mucosal lesion, and hematologic abnormalities.
INTRODUCTION
Adverse cutaneous drug reactions (ACDRs) are the most frequent adverse events resulting from drug treatment. Studies have
shown that up to 6.7% of hospitalized patients present some degree of ACDR, with severe forms ranging from 0.33% to 3%. [1] [2] [3] Although the rate of severe cutaneous adverse drug reaction (SCADRs) is low, these reactions can affect anyone who takes medications and can result in death or disability. 4 The World Health Organization defines SCARDs are those requiring hospitalization or that extend the length of hospital stay, resulting in persistent or significant disability or life-threatening. 3 The spectrum of SCADRs includes Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and drug-induced hypersensitivity syndrome (DIHS)/ Drug rash with eosinophilia and systemic symptoms (DRESS). 5 DIHS is a new type of adverse drug reaction (ADR) and is considered a SCADR. In China, exfoliative dermatitis (ED) is also classified as SCADR.
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During the past 15 years, numerous studies regarding
SCADRs have been reported in China. However, there were inconsistent results and insufficient statistical power. Moreover, it is very important to acquire knowledge on SCARDs for their great impact on morbidity and mortality rates, and on hospital costs. These reasons motivated us to carry out this study to explore the characteristics of SCADRs of Chinese inpatients. 
METHODS

Selection
Inclusion criteria
The following criteria were used: (1) The study objects were the Chinese inpatients with severe drug eruptions; (2) All the arti- .001]. The man to woman ratio was 1.14:1. 
RESULTS
Literature retrieval
History of drug allergy
Clinical subtypes
Clinical subtypes of SCADRs were analyzed in 25 articles.
As shown in Figure 3, Table 3 .
Physical and laboratory examinations
As shown in Figure 4 , fever was implicated in 73.0% of cases; 63.8% of the patients had mucosal lesions (ML) (given the insufficiency of other data of physical examinations, such as edema, lymphadenomegaly, etc., only fever and ML were analyzed). Blood routine abnormality (BRA) was presented in 66.7%. 
Publication bias
In this meta-analysis, there was no significant publication bias for gender proportion, history of drug allergy, physical and laboratory examinations. However, possible publication bias may exist for causative drugs, clinical subtypes, relation between causative drugs and clinical subtypes. Publication bias is derived from exclusion of results that were not published. We specifically acknowledge the limitations and expect more studies. Nevertheless, a possible publication bias does not affect the main results.
Influence analysis
Influence analysis was performed to investigate the influence of a single study on the overall analysis. The heterogeneities were not changed significantly after exclusion of any single study.
Furthermore, the corresponding pooled standardized mean difference (SMD) and 95% CI were not conspicuously altered with any single study excluded. Therefore, the reliability of the results was enhanced by the influence analysis. In this meta-analysis, men predominance was found in
Studies
Chinese inpatients with SCADRs, coincident with previous studies. 5, 35, 36 This study also demonstrated that 21.3% of the patients had a history of drug allergy. People with a history of drug allergy may present a defect of detoxification function, which makes them more vulnerable to suffer drug eruptions.
Similar to previous studies, this meta-analysis manifested antibiotics (29.2%) were the most frequent causative drugs for SCADRs, followed by SHA (26.0%). 5,36-38 AA were implicated in 17.1% of the patients. Inconsistently, some studies reported antibiotics and allopurinol were the most common culprit drugs. 32, 39 It is 
